OpenURL Connection Search

Select item for more details and to access through your institution.

Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis.
Published in:
1998
By:
- Benvegnù, Luisa;
- Chemello, Liliana;
- Noventa, Franco;
- Fattovich, Giovanna;
- Pontisso, Patrizia;
- Alberti, Alfredo;
- Benvegnù, L;
- Chemello, L;
- Noventa, F;
- Fattovich, G;
- Pontisso, P;
- Alberti, A
Publication type:
journal article
Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
Published in:
1994
By:
- Benvegnù, Luisa;
- Fattovich, Giovanna;
- Noventa, Franco;
- Tremolada, Federico;
- Chemello, Liliana;
- Cecchetto, Attilio;
- Alberti, Alfredo;
- Benvegnù, L;
- Fattovich, G;
- Noventa, F;
- Tremolada, F;
- Chemello, L;
- Cecchetto, A;
- Alberti, A
Publication type:
journal article
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 1, p. 160, doi. 10.1111/apt.13821
By:
- Petta, S.;
- Cabibbo, G.;
- Barbara, M.;
- Attardo, S.;
- Bucci, L.;
- Farinati, F.;
- Giannini, E. G.;
- Tovoli, F.;
- Ciccarese, F.;
- Rapaccini, G. L.;
- Di Marco, M.;
- Caturelli, E.;
- Zoli, M.;
- Borzio, F.;
- Sacco, R.;
- Virdone, R.;
- Marra, F.;
- Felder, M.;
- Morisco, F.;
- Benvegnù, L.
Publication type:
Article
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
Published in:
Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 4, p. 493, doi. 10.1111/j.1365-2036.2009.04198.x
By:
- GIANNINI, E. G.;
- BODINI, G.;
- CORBO, M.;
- SAVARINO, V.;
- RISSO, D.;
- DI NOLFO, M. A.;
- DEL POGGIO, P.;
- BENVEGNÙ, L.;
- FARINATI, F.;
- ZOLI, M.;
- BORZIO, F.;
- CATURELLI, E.;
- CHIARAMONTE, M.;
- TREVISANI, F.
Publication type:
Article
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.
Published in:
2004
By:
- Pontisso, P.;
- Calabrese, F.;
- Benvegnù, L.;
- Lise, M.;
- Belluco, C.;
- Ruvoletto, M. G.;
- de Falco, S.;
- Marino, M.;
- Valente, M.;
- Nitti, D.;
- Gatta, A.;
- Fassina, G.
Publication type:
Correction Notice
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.
Published in:
British Journal of Cancer, 2004, v. 90, n. 4, p. 833, doi. 10.1038/sj.bjc.6601543
By:
- Pontisso, P.;
- Calabrese, F.;
- Benvegnù, L.;
- Lise, M.;
- Belluco, C.;
- Ruvoletto, M. G.;
- de Falco, S.;
- Marino, M.;
- Valente, M.;
- Nitti, D.;
- Gatta, A.;
- Fassina, G.
Publication type:
Article
Fibrosis progression in initially mild chronic hepatitis C.
Published in:
Journal of Viral Hepatitis, 2006, v. 13, n. 5, p. 297, doi. 10.1111/j.1365-2893.2005.00683.x
By:
- Boccato, S.;
- Pistis, R.;
- Noventa, F.;
- Guido, M.;
- Benvegnù, L.;
- Alberti, A.
Publication type:
Article

Found: 7

Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis.

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.

Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.

Fibrosis progression in initially mild chronic hepatitis C.